Literature DB >> 20883478

Tolerance to allopregnanolone with focus on the GABA-A receptor.

Sahruh Turkmen1, Torbjorn Backstrom, Goran Wahlstrom, Lotta Andreen, Inga-Maj Johansson.   

Abstract

Many studies have suggested a relationship between stress, sex steroids, and negative mental and mood changes in humans. The progesterone metabolite allopregnanolone is a potent endogenous ligand of the γ-amino butyric acid -A (GABA-A) receptor, and the most discussed neuroactive steroid. Variations in the levels of neuroactive steroids that influence the activity of the GABA-A receptor cause a vulnerability to mental and emotional pathology. There are physiological conditions in which allopregnanolone production increases acutely (e.g. stress) or chronically (e.g. menstrual cycle, pregnancy), thus exposing the GABA-A receptor to high and continuous allopregnanolone concentrations. In such conditions, tolerance to allopregnanolone may develop. We have shown that both acute and chronic tolerances can develop to the effects of allopregnanolone. Following the development of acute allopregnanolone tolerance, there is a decrease in the abundance of the GABA-A receptor α4 subunit and the expression of the α4 subunit mRNA in the ventral-posteriomedial nucleus of the thalamus. Little is known about the mechanism behind allopregnanolone tolerance and its effects on assembly of the GABA-A receptor composition. The exact mechanism of the allopregnanolone tolerance phenomena remains unclear. The purpose of this review is to summarize certain aspects of current knowledge concerning allopregnanolone tolerance and changes in the GABA-A receptors.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20883478      PMCID: PMC3031054          DOI: 10.1111/j.1476-5381.2010.01059.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  190 in total

1.  Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition.

Authors:  Jan-Jurjen Koksma; Ronald E van Kesteren; Thomas W Rosahl; Ruud Zwart; August B Smit; Hartmut Lüddens; Arjen B Brussaard
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

2.  Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal.

Authors:  L L Devaud; J M Fritschy; W Sieghart; A L Morrow
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

3.  Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam.

Authors:  F Impagnatiello; C Pesold; P Longone; H Caruncho; J M Fritschy; E Costa; A Guidotti
Journal:  Mol Pharmacol       Date:  1996-05       Impact factor: 4.436

4.  Rapid non-genomic effect of glucocorticoid metabolites and neurosteroids on the gamma-aminobutyric acid-A receptor.

Authors:  J Strömberg; T Bäckström; P Lundgren
Journal:  Eur J Neurosci       Date:  2005-04       Impact factor: 3.386

5.  Chronic pentobarbital administration alters gamma-aminobutyric acidA receptor alpha 6-subunit mRNA levels and diazepam-insensitive [3H]Ro15-4513 binding.

Authors:  T Ito; T Suzuki; S E Wellman; I K Ho
Journal:  Synapse       Date:  1996-02       Impact factor: 2.562

6.  Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat.

Authors:  M Gulinello; Q H Gong; X Li; S S Smith
Journal:  Brain Res       Date:  2001-08-10       Impact factor: 3.252

Review 7.  Molecular biology of GABAA receptors.

Authors:  R W Olsen; A J Tobin
Journal:  FASEB J       Date:  1990-03       Impact factor: 5.191

Review 8.  The neurobiology of postpartum depression.

Authors:  Jessica Zonana; Jack M Gorman
Journal:  CNS Spectr       Date:  2005-10       Impact factor: 3.790

9.  Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.

Authors:  I Sundström; A Andersson; S Nyberg; D Ashbrook; R H Purdy; T Bäckström
Journal:  Neuroendocrinology       Date:  1998-02       Impact factor: 4.914

10.  Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being.

Authors:  I-S Odmark; T Bäckström; B Jonsson; M Bixo
Journal:  Gynecol Endocrinol       Date:  2004-06       Impact factor: 2.260

View more
  30 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

2.  A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression.

Authors:  Liisa Hantsoo; Deborah Ward-O'Brien; Kathryn A Czarkowski; Ralitza Gueorguieva; Lawrence H Price; C Neill Epperson
Journal:  Psychopharmacology (Berl)       Date:  2013-10-31       Impact factor: 4.530

Review 3.  The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disorders.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

Review 4.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

5.  Roux-en-Y Gastric Bypass Surgery in Patients with Polycystic Ovary Syndrome and Metabolic Syndrome.

Authors:  Sahruh Turkmen; Alebtekin Ahangari; Torbjörn Bäckstrom
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

6.  Women with PTSD have a changed sensitivity to GABA-A receptor active substances.

Authors:  Anna Tiihonen Möller; Torbjörn Bäckström; Sigrid Nyberg; Hans Peter Söndergaard; Lotti Helström
Journal:  Psychopharmacology (Berl)       Date:  2014-10-28       Impact factor: 4.530

Review 7.  Sex differences in fear extinction.

Authors:  E R Velasco; A Florido; M R Milad; R Andero
Journal:  Neurosci Biobehav Rev       Date:  2019-05-23       Impact factor: 8.989

Review 8.  Neuroactive steroids for the treatment of status epilepticus.

Authors:  Michael A Rogawski; Carlos M Loya; Kiran Reddy; Dorota Zolkowska; Christoph Lossin
Journal:  Epilepsia       Date:  2013-09       Impact factor: 5.864

9.  Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study.

Authors:  Ariadna Forray; Kathryn Gilstad-Hayden; Cristine Suppies; Debra Bogen; Mehmet Sofuoglu; Kimberly A Yonkers
Journal:  Psychoneuroendocrinology       Date:  2017-09-14       Impact factor: 4.905

Review 10.  Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review.

Authors:  MacKenzie R Peltier; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.